Camurus Email Format

Pharmaceutical ManufacturingSkåne, Sweden201-500 Employees

Camurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases. We empower patients, support caregivers and create value for society by developing and giving access to innovative, long-acting medicines. To fulfill our commitment, we are determined to conduct our business in a sustainable manner.

New drug products with best-in-class potential are conceived based on the company's proprietary FluidCrystal® technology and extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of treatment of opioid dependence, cancer, and endocrine disorders, which are developed in-house and in collaboration with international pharmaceutical companies. 

The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. 

✕

Access Insights for Camurus and Millions of Other Companies

Sign up for full access to Camurus information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory